Architecture for a Federated Drug Reference in a managed care environment.

Architecture for a Federated Drug Reference in a managed care environment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Architecture for a Federated Drug Reference in a managed care environment. Abstract Text:

D S Ketchell,K N Ibrahim,N A Murri,P S Wareham,D M Bell,T A Jankowski,

We describe a model of drug information query management that supports the integration of various types of pharmaceutical information and the delivery of that information through a common interface. Our prototype drug reference system makes use of the World Wide Web client/server architecture as a front-end to federate this data. Although originally intended as an electronic Hospital Formulary, the system has been redefined as a result of input from physicians to include formularies of multiple managed care plans. The underlying database is designed for integration with an electronic medical record as well as education and research resources for faculty and students in an academic medical center environment.

Architecture for a Federated Drug Reference in a managed care environment. Publishing Authors By Initials

DS Ketchell,KN Ibrahim,NA Murri,PS Wareham,DM Bell,TA Jankowski,

For similar natural sciences: science: systems integration research abstracts see: natural sciences: science: systems integration research

PUBMED ID PMID:

MEDLINE DATE:

Architecture for a Federated Drug Reference in a managed care environment. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Proceedings : a conference of the American Medical

VOLUME:

Page Numbers: 413-7

Journal Abbreviation:

ISSN: 1091-8280

DAY: 15

MONTH: 01

YEAR: 1996

Architecture for a Federated Drug Reference in a managed care environment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9617342

Architecture for a Federated Drug Reference in a managed care environment. Keywords Mesh Terms:

KEYWORDS: Systems Integration

MESH TERMS:

Chemical & Substance for Abstract: Architecture for a Federated Drug Reference in a managed care environment. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Architecture for a Federated Drug Reference in a managed care environment.

AFFILIATION: University of Washington Health Sciences Center, Seattle, USA.

Country: UNITED STATES

AGENCY: United States NLM

GRANT: G08 LM5050

ACRONYM: LM

MEDLINETA: Proc AMIA Annu Fall Symp

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Architecture for a Federated Drug Reference in a managed care environment Related Publications

• A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response.
• Architecture for a Federated Drug Reference in a managed care environment.
• Association of HLA-*08:DRB1*03 with immunoglobulin A-deficiency.
• Chemoprevention of colorectal cancer.
• Damage to the nucleus accumbens shell but not core impairs ventral tegmental area stimulation-induced feeding.
• Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.
• Determination of pore diameter and molecular weight cut-off of hydrogel-membrane liquid-core capsules for immunoisolation.
• Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus--the glass is half full!
• Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention.
• Functional arginine vasopressin system in early heart maturation.
• Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility.
• Influence of subinhibitory concentrations of amikacin and ciprofloxacin on morphology and adherence ability of uropathogenic strains.
• Mortality rates in patients with Barrett's oesophagus.
• Review on uraemic solutes II Variability in reported concentrations: causes and consequences.
• Spatial frequency tuning and contrast threshold of striate neurons in Siamese cats.
• Uridine adenosine tetraphosphate acts as an autocrine hormone affecting glomerular filtration rate.
• [Comparative studies of the system of hearing in children after jaundice due to serological conflict and jaundice without such conflict]
• [Effect of acoustic conditions on hearing acuity in selected groups of workers at the State Railway Car Manufacture Plant in Wroc?aw]
• [Endotracheal anesthesia in tonsil surgery in children.]
• [Epistaxis (with treatment)]
• [Etiopathogenesis and diagnosis of Ménière's disease]
• [Hydrogel dressings in the otolaryngological practice]
• [Life and scientific works of Prof. Wiktor Jankowski (on his 80th birthday)]
• [Ototoxicity of sodium salicylate]
• [Role of cytokines in pathomechanism of otitis media]
• [The role of JNK pathway in familial Parkinson's disease]
• [The significance of rotation tests in diagnosis of vestibule and otolith]
• [The test of the rotating wheel]
• [Wegener's granulomatosis--diagnostic problem]
• [Willebrand factor deficiency and septorhinoplasty]